Tag:
Botox
Latest Headlines
Latest Headlines
Allergan to enlist new hires in R&D expansion
Allergan has ambitious plans to swell its ranks with the opening of a new R&D facility in the Garden State. The news comes amid a major push at Allergan to expand the use of Botox far beyond fixing facial wrinkles and to develop therapies for a variety of ailments.
Allergan asks FDA for lucrative new Botox indication
Allergan has asked U.S. and European regulators to approve Botox to treat patients with garden-variety overactive bladder, citing two Phase III trials.
Allergan wins injunction against Botox rival
Allergan won its injunction against a putative Botox competitor that had already grabbed 8% of the U.S. market after its first few weeks on sale. Germany's Merz Group was accused of appropriating Allergan's trade secrets in launching the alternative botulinum toxin drug Xeomin, and now faces 10 months off the cosmeceuticals market.
NICE holds out for more data on Botox for migraine
The U.K.'s cost-effectiveness watchdog is looking askance at Botox for chronic migraine. The National Institute for Health and Clinical Excellence has asked Allergan ( $AGN ) for more data to back up
Allergan to plow $350M into bigger Botox capacity
Allergan ( $AGN ) has big building plans in Ireland. The U.S.-based company says it's planning to spend 270 million euros, or $350 million, to expand a Westport plant, creating 200 new jobs over the
Surgeon sues Allergan over large Botox vials
Las Vegas appears to be becoming an epicenter of protest against large vials of injectable drugs. A plastic surgeon in that city has sued Allergan ( $AGN ), saying the drugmaker is marketing Botox in
NJ wins heated competition for Allergan's new R&D facility
New Jersey officials are celebrating Allergan's ( $AGN ) decision to build a new 100,000-square-foot, $12 million R&D facility in the state, adding up to 400 research jobs over the next five years.
Bladder nod for Botox first step to $400M in extra sales
Allergan ( $AGN ) has successfully opened up a new field for Botox: bladder control. The company won FDA approval for use of the injectable muscle relaxant to prevent overactive bladder in patients
NICE to assess uses for Botox, Revlimid, Tarceva
The U.K.'s cost-effectiveness watchdog has marching orders to weigh the effectiveness and efficiency of new uses for three drugs. The National Institute for Health and Clinical Excellence will review
Botox gets EU green light as bladder treatment
Last week, Allergan CEO David Pyott was talking up a new indication for the wrinkle drug Botox, quoting analyst estimates that it could add hundreds of millions to annual sales. This week, Irish
